|
gptkbp:instanceOf
|
gptkb:antibiotic
|
|
gptkbp:administeredBy
|
injection
oral
|
|
gptkbp:ATCCode
|
J01GB04
|
|
gptkbp:CASNumber
|
59-01-8
|
|
gptkbp:contraindication
|
gptkb:myasthenia_gravis
pregnancy
|
|
gptkbp:discoveredBy
|
gptkb:Hamao_Umezawa
|
|
gptkbp:discoveredIn
|
1957
|
|
gptkbp:eliminatedIn
|
renal
|
|
gptkbp:hasMolecularFormula
|
C18H36N4O11
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
inhibits protein synthesis
|
|
gptkbp:molecularWeight
|
484.5 g/mol
|
|
gptkbp:pregnancyCategory
|
D (US)
|
|
gptkbp:producedBy
|
gptkb:Streptomyces_kanamyceticus
|
|
gptkbp:PubChem_CID
|
6032
DB01172
|
|
gptkbp:resistantTo
|
gptkb:kanamycin_resistance_gene_(kanR)
|
|
gptkbp:sideEffect
|
nephrotoxicity
allergic reactions
ototoxicity
|
|
gptkbp:synonym
|
gptkb:Kanamycin_sulfate
gptkb:Kantrex
|
|
gptkbp:target
|
gptkb:bacterial_30S_ribosomal_subunit
|
|
gptkbp:usedFor
|
treatment of bacterial infections
treatment of tuberculosis
|
|
gptkbp:WHOModelListOfEssentialMedicines
|
included
|
|
gptkbp:bfsParent
|
gptkb:pKM101
|
|
gptkbp:bfsLayer
|
6
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
kanamycin
|